Maitland Fire Rescue Department Practice Parameters - Revision history

Mfrdmanager: /* Section 2 - Primary Care */

2025-12-17T16:24:10Z

‎Section 2 - Primary Care

2025-12-17T16:20:49Z

‎Section 8 - Medication Guidelines

2025-12-17T16:16:35Z

‎Section 2 - Primary Care

2025-12-17T16:16:08Z

‎Section 2 - Primary Care

2025-12-09T13:53:34Z

‎Section 8 - Medication Guidelines

2025-10-29T18:13:35Z

‎Section 8 - Medication Guidelines

2025-10-29T18:13:10Z

‎Section 8 - Medication Guidelines

2023-04-13T18:25:35Z

‎Section 5 - Medical

2020-11-16T15:39:43Z

‎Section 9 - Procedure Guidelines

2020-11-16T15:37:39Z

‎Section 9 - Procedure Guidelines

@@ Line 66: / Line 66: @@
 ||2.03 ||[[Rapid Trauma Assessment, Focused History and Physical Exam]]||Sept-15
 |-
-||2.04||[[Analgesia and Sedation]]||November-2017
+||2.04||[[Analgesia and Sedation]]||November-17
 |-
-||2.05||[[Drug Assisted Intubation]]||December-2016
+||2.05||[[Drug Assisted Intubation]]||December-16
 |-
-|2.06||[[DISSOCIATIVE ANESTHETIC]]||
+|2.06||[[DISSOCIATIVE ANESTHETIC]]||September-24
 |-
 |||[[Patient Assist]]||January-25

@@ Line 290: / Line 290: @@
 |-
 |[[Glucagon]]||April-16
 |-
 |[[Keppra]]||September-24

@@ Line 72: / Line 72: @@
 |2.06||[[DISSOCIATIVE ANESTHETIC]]||
 |-
-|[[Patient Assist]]||January-25
+|||[[Patient Assist]]||January-25
 |}

@@ Line 69: / Line 69: @@
 |-
 ||2.05||[[Drug Assisted Intubation]]||December-2016
 |}

@@ Line 286: / Line 286: @@
 |-
 |[[Glucagon]]||April-16
 |-
 |[[Ketamine]]||November-17

@@ Line 293: / Line 293: @@
 |[[Lidocaine]]||July-17
 |-
-|[[Magnesium Sulfate]]||Nov-25
+|[[Magnesium Sulfate]]||November-25
 |-
 |[[Morphine Sulfate]]||November-16

@@ Line 136: / Line 136: @@
 |5.03||[[Altered Mental Status (AMS)]]||April-17
 |-
-|5.04||[[Suspected Stroke Transcient Ischemic Attack TIA|Suspected Stroke or Transcient Ischemic Attack]]||May-18
+|5.04||[[Suspected Stroke Transient Ischemic Attack TIA|Suspected Stroke or Transient Ischemic Attack]]||May-18
 |-
 |5.05||[[Drug Overdose Poisoning]]||March-09

@@ Line 413: / Line 413: @@
 |9.33||[[Combat Application Tourniquet]]||Jan-14
 |-
-|9.34||[[http://lifevest.zoll.com/medical-professionals/first-responder-resources Zoll LifeVest Wearable Defibrillator]||Dec-14
+|9.34||[http://lifevest.zoll.com/medical-professionals/first-responder-resources Zoll LifeVest Wearable Defibrillator]||Dec-14
 |-
 |9.35||[[Medication Temperature Monitoring]]||Feb-19

@@ Line 405: / Line 405: @@
 |9.29||[[Transcutaneous Pacing Procedure]]||March-09
 |-
-|9.30||[[Transcutaneous Pacing Procedure]]||March-09
+|9.30||[[Emergency Escharotomy|Emergency Chest Wall Escharotomy]]||April-11
 |-
-|9.31||[[ResQGuard Impedance Threshold Device]]||April-11
+|9.31||[[Central Venous Access Devices]]||June-12
 |-
-|9.32||[[Emergency Escharotomy|Emergency Chest Wall Escharotomy]]||April-11
+|9.32||[[Medication Administration Cross Check]]||Jun-12
 |-
-|9.33||[[Central Venous Access Devices]]||June-12
+|9.33||[[Combat Application Tourniquet]]||Jan-14
 |-
-|9.34||[[Medication Administration Cross Check]]||Jun-12
+|9.34||[[http://lifevest.zoll.com/medical-professionals/first-responder-resources Zoll LifeVest Wearable Defibrillator]||Dec-14
 |-
-|9.35||[[Combat Application Tourniquet]]||Jan-14
+|9.35||[[Medication Temperature Monitoring]]||Feb-19
 |}